PRDX6 as a promoter of cancer malignancy in hepatocarcinoma cell lines targeting GSK3B

ABSTRACT: This project describes the mechanism by wich PRDX6 affects migration and invasiveness in hepatocarcinoma cells. SNU475 (mesenchymal) hepatocarcinoma cell line knockout for PRDX6 showed a marked increase in ROS and lipid peroxidation, mytochondrial dysfunction, metabolic reprogramming, altered cytoskeleton and activation of upstream regulators MYC, ATF4, HNF4A and HNF4G and inhibition of NRF2 and TP53. All these changes point to a role of PRDX6 in tumor development pointing to it as a candidate for antitumoral therapies.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Permanent Cell Line Cell, Cell Culture

DISEASE(S): Hepatocellular Carcinoma

SUBMITTER: Raquel Requejo-Aguilar  

LAB HEAD: Raquel Requejo Aguilar

PROVIDER: PXD039491 | Pride | 2023-07-20

REPOSITORIES: Pride